DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Outcomes of Vitrectomy Combined With Subtenon Triamcinolone Injection for the Idiopathic Epiretinal Membrane

Information source: Yeungnam University College of Medicine
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Epiretinal Membrane

Intervention: Vitrectomy only group (Procedure); Combined therapy group (Procedure)

Phase: N/A

Status: Recruiting

Sponsored by: Yeungnam University College of Medicine

Summary

This study compares the anatomical and visual outcomes of patients with idiopathic epiretinal membrane(ERM) treated by vitrectomy and membrane peeling with or without subtenon triamcinolone acetonide injection

Clinical Details

Official title: Anatomic and Functional Outcomes of 23-gauge Vitrectomy Combined With Posterior Subtenon Triamcinolone Injection for the Treatment of Idiopathic Epiretinal Membrane

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome: Changes of best corrected visual acuity and central retinal thickness

Secondary outcome: Changes in status of ISOS line

Eligibility

Minimum age: 20 Years. Maximum age: 80 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- 1. The participant must have idiopathic epiretinal membrane 2. The participant must be

willing and able to comply with the protocol. Exclusion Criteria:

- 1. The participant has idiopathic epiretinal membrane with other ocular vascular

diseases such as Diabetes retinopathy, BRVO, etc. 2. The participant has any additional ocular diseases that have irreversibly compromised or could likely compromise the visual acuity of the study eye including amblyopia, anterior ischemic optic neuropathy, clinically significant diabetic macular edema, severe non proliferative diabetic retinopathy, or proliferative diabetic retinopathy. 3. The participant has had intraocular surgery (including lens replacement surgery). 4. The participant has a history of (within the last six months), or current ocular or periocular infection (including any history of ocular herpes zoster or simplex).

Locations and Contacts

Yeungnam University College of Medicine, Daegu 705-717, Korea, Republic of; Recruiting
Min Sagong, Phone: 82-53-620-4191, Email: msagong@ynu.ac.kr
Min Sagong, Principal Investigator
Additional Information

Starting date: January 2012
Last updated: October 1, 2012

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017